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Only limited information is available about the immunopathogenic properties of Arcobacter
infection in vivo. Therefore, we performed ameta-analysis of published data in murine infection
models to compare the pathogenic potential of Arcobacter butzleriwithCampylobacter jejuni
and commensal Escherichia coli as pathogenic and harmless reference bacteria, respectively.
Methodology / Principal Findings
Gnotobiotic IL-10-/- mice generated by broad-spectrum antibiotic compounds were perorally
infected with A. butzleri (strains CCUG 30485 or C1),C. jejuni (strain 81-176) or a commensal
intestinal E. coli strain. Either strain stably colonized the murine intestines upon infection. At
day 6 postinfection (p.i.),C. jejuni infected mice only displayed severe clinical sequelae such
as wasting bloody diarrhea. Gross disease was accompanied by increased numbers of
colonic apoptotic cells and distinct immune cell populations including macrophages and
monocytes, T and B cells as well as regulatory T cells upon pathogenic infection. Whereas A.
butzleri and E. coli infected mice were clinically unaffected, respective colonic immune cell
numbers increased in the former, but not in the latter, and more distinctly upon A. butzleri
strain CCUG 30485 as compared to C1 strain infection. Both, A. butzleri andC. jejuni induced
increased secretion of pro-inflammatory cytokines such as IFN-γ, TNF, IL-6 and MCP-1 in
large, but also small intestines. Remarkably, even though viable bacteria did not translocate
from the intestines to extra-intestinal compartments, systemic immune responses were
induced inC. jejuni, but also A. butzleri infected mice as indicated by increased respective
pro-inflammatory cytokine concentrations in serum samples at day 6 p.i.
Conclusion / Significance
A. butzleri induce less distinct pro-inflammatory sequelae as compared to C. jejuni, but
more pronounced local and systemic immune responses than commensal E. coli in a strain-
dependent manner. Hence, data point towards that A. butzleri is more than a commensal in
vertebrate hosts.
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Introduction
The gram-negative Arcobacter species belong to the Campylobacteraceae family and can be
found in a plethora of habitats. In animals, Arcobacter spp. are mostly regarded as gastrointesti-
nal commensals [1]. In humans, however, Arcobacter spp. have been shown to induce single
diarrheal cases, but also disease outbreaks have been reported [2, 3]. Patients become infected
by contaminated food or water and present with symptoms of acute gastroenteritis such as
abdominal pain, acute or even prolonged diarrhea for up to several weeks [4, 5]. Since identifi-
cation of Arcobacter spp. may fail in routine diagnostic laboratories, robust epidemiological
data on Arcobacter associated human disease are lacking. In a prospective German study, for
instance, no Arcobacter at all could be isolated in hospitalized patients suffering from commu-
nity acquired acute gastroenteritis [6]. Van den Abeele and colleagues, however, reported in a
large survey an Arcobacter prevalence of 1.3% in stool samples derived from more than 6700
Belgian enteritis patients [5]. In studies from New Zealand, Thailand and Mexico, Arcobacter
spp. such as A. butzleri and A. cryaerophilus could be detected in 0.9–8.0% of fecal samples
obtained from diarrheal patients [7–9]. Isolation rates, however, were highly depending on the
respective cultivation methods applied in the respective microbiology laboratories [5]. It is
therefore highly likely that the prevalence rates reported so far have been rather underesti-
mated. In line with this, a very recent Canadian study revealed A. butzleri isolation rates of
59.6% and 0.8% from stool samples determined by PCR-based and culture-dependent meth-
ods, respectively [10]. Remarkably, neither differences could be found in fecal A. butzleri preva-
lences between diarrheal and non-diarrheal patients, nor did patient age, sex or place of
habitation correlate with A. butzleri positive results in fecal samples derived by quantitative
real-time PCR [10]. Thus, it is still an open and unanswered question whether Arcobacter spp.
need to be regarded as ordinary commensals or rather pathogenic species. Nevertheless, based
upon retrospective studies Arcobacter is estimated the fourth most common Campylobacterales
genus isolated from diarrheal patients [4, 5, 11]. Furthermore, the International Commission
on Microbiological Specifications for Foods have rated A. butzleri and A. cryaerophilus as seri-
ous hazards for human health among the 21 so far described Arcobacter species [12]. Until
now information regarding the underlying mechanisms of Arcobacter infection and bacteria-
host interactions are scarce due to lack of suitable in vivo infection models. Very recently our
group showed in gnotobiotic (i.e. secondary abiotic) IL-10-/- mice, a well-established murine
model of C. jejuni infection, that A. butzleri induced intestinal and systemic immune responses
[13, 14]. These immune reponses were highly dependent on Toll-like-receptor (TLR) -4 consti-
tuting the main receptor for lipooligosaccharide (LOS) and lipopolysaccharide (LPS) from
gram-negative bacteria [15, 16]. In the present study we assessed the immunopathological
potential of A. butzeri by comparing our published, but also so far unpublished data from gno-
tobiotic IL-10-/- mice infected with the pathogen C. jejuni or a commensal intestinal E. coli
strain [17, 18]. In this meta-analysis we aimed to unravel whether A. butzleri exhibited immu-
nopathological features of a pathogen or a commensal.
Materials and Methods
Ethics statement
All animal experiments were conducted according to the European Guidelines for animal wel-
fare (2010/63/EU) with approval of the commission for animal experiments headed by the
“Landesamt für Gesundheit und Soziales” (LaGeSo, Berlin, registration numbers G0173/07,
G0135/10, and G0184/12). Animal welfare was monitored twice daily by assessment of clinical
conditions.
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Study design
Data were pooled from separate published [13, 14, 17, 18] as well as so far unpublished animal
trials.
Generation of gnotobiotic IL-10-/- mice
IL-10-/- mice (in C57BL/10 background, B10) were bred and kept in the facilities of the “For-
schungseinrichtungen für Experimentelle Medizin” (FEM, Charité - Universitätsmedizin, Ber-
lin, Germany) under specific pathogen-free (SPF) housing conditions. Gnotobiotic IL-10-/-
mice were generated by broad-spectrum antibiotic treatment as described earlier [19]. In brief,
mice were kept in sterile cages and and had ad libitum access to an antibiotic cocktail consisting
of ampicillin/sulbactam (1 g/L; Pfizer, Berlin, Germany), vancomycin (500 mg/L; Hexal, Holz-
kirchen, Germany), ciprofloxacin (200 mg/L; Hexal, Holzkirchen, Germany), imipenem (250
mg/L; Fresenius Kabi, Graz, Austria), and metronidazole (1 g/L; Braun, Melsungen, Germany)
in drinking water starting at 3 weeks of age immediately after weaning and continued for 3–4
months before the infection experiment [20]. Three days prior infection, the antibiotic cocktail
was replaced by sterile tap water (ad libitum). These so generated gnotobiotic (i.e. secondary
abiotic) mice were continuously kept in a sterile environment (with autoclaved food and drink-
ing water), handeled under strict aseptic conditions and displayed a virtually depleted gastroin-
testinal microbiota.
Bacterial strains
A commensal E. coli strain was isolated from our naive and conventionally colonized C57BL/6
wildtype mice as described earlier [19]. No known virulence factors of pathogenic E. coli such
as stx-1 and -2, catA, hlyA, cspA, katP and astA could be detected by PCR analysis in a reference
laboratory [18]. The A. butzleri reference strain CCUG 30485 was derived from a fecal sample
of a diarrheal patient [21], whereas the C1 strain was isolated from fresh chicken meat [22]. As
a pathogenic reference strain, C. jejuni strain 81-176 was chosen.
Infection of mice
Gnotobiotic IL-10-/- mice were infected with 109 colony forming units (CFU) of C. jejuni strain
81-176, A. butzleri reference strain CCUG 30485 or strain C1, or a commensal E. coli strain by
gavage in a total volume of 0.3 mL PBS on two consecutive days (day 0 and day 1) as described
earlier in more detail [13, 14, 17, 18].
C. jejuni and both A. butzleri strains were grown on Karmali-Agar and Columbia Agar sup-
plemented wit 5% sheep blood (both from Oxoid, Wesel, Germany) for two days at 37°C under
microaerobic conditions using CampyGen gas packs (Oxoid), whereas the commensal E. coli
was cultivated on MacConkey agar (Oxoid) for one day at 37°C in aerobic atmosphere.
Clinical Score
A standardized cumulative clinical score (maximum 12 points), addressing the occurrence of
blood in feces (0 points: no blood; 2 points: microscopic detection of blood by the Guajac
method using Haemoccult, Beckman Coulter / PCD, Krefeld, Germany; 4 points: overt blood
visible), diarrhea (0: formed feces; 2: pasty feces; 4: liquid feces), and the clinical aspect (0: nor-
mal; 2: ruffled fur, less locomotion; 4: isolation, severely compromized locomotion, pre-final
aspect) was used in order to assess clinical signs of infection [13, 17].
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Sampling procedures
Mice were sacrificed by isofluran treatment (Abbott, Greifswald, Germany). Then, cardiac
blood was taken and tissue samples removed from spleen, liver, mesenteric lymph nodes
(MLN), ileum, and colon, all under sterile conditions. Ileal and colonic ex vivo biopsies were
collected from each mouse in parallel, for microbiological, immunohistochemical and immu-
nological analyses. Immunohistopathological changes were determined in colonic samples that
had been immediately fixed in 5% formalin and embedded in paraffin. Sections (5 μm) were
stained with respective antibodies for in situ immunohistochemistry as described earlier [13,
20].
Immunohistochemistry
In situ immunohistochemical analysis of colonic paraffin sections was performed as described
previously [13, 17, 18, 23, 24]. In brief, primary antibodies against cleaved caspase-3 (Asp175,
Cell Signaling, USA, 1:200), CD3 (#N1580, Dako, Denmark, dilution 1:10), FOXP3 (FJK-16s,
eBioscience, 1:100), B220 (eBioscience, 1:200), and F4/80 (# 14–4801, clone BM8, eBioscience,
San Diego, CA, USA, 1:50) were used [13]. For each animal, the average number of positively
stained cells within at least six high power fields (HPF, 400 x magnification) were determined
microscopically by a double-blinded investigator [13].
Quantitative analysis of bacterial colonization and translocation
Viable A. butzleri, C. jejuni and commensal E. coli were detected in feces or at time of necropsy
(day 6 p.i.) in luminal samples taken from the ileum or colon and dissolved in sterile PBS. Serial
dilutions were cultured on Karmali- and Columbia-Agar supplemented with 5% sheep blood
(Oxoid) for two days at 37°C under microaerobic conditions using CampyGen gas packs
(Oxoid) for A. butzleri and C. jejuni detection, whereas E. coli was cultivated on MacConkey
and Columbia-Agar supplemented with 5% sheep blood (Oxoid) for 48 hours in aerobic atmo-
sphere. In order to quantitatively assess bacterial translocation, MLN, spleen, and liver ex vivo
biopsies were homogenized in 1 mL sterile PBS, whereas cardiac blood (200 μL) was directly
streaked onto respective solid media and cultivated accordingly. The respective weights of fecal
or tissue samples were determined by the difference of the sample weights before and after
asservation. The detection limit of viable pathogens by direct plating was 100 CFU per gram.
Cytokine detection
Ileal and colonic ex vivo biopsies were cut longitudinally, washed in PBS, and strips of approxi-
mately 1 cm2 intestinal tissue placed in 24-flat-bottom well culture plates (Nunc, Wiesbaden,
Germany) containing 500 μL serum-free RPMI 1640 medium (Gibco, life technologies, Paisley,
UK) supplemented with penicillin (100 U/ mL) and streptomycin (100 μg/ mL; PAA Laborato-
ries). After overnight incubation at 37°C, culture supernatants and serum samples were tested
for IFN-γ, TNF, IL-6, and MCP-1 by the Mouse Inflammation Cytometric Bead Assay (CBA;
BD Biosciences) on a BD FACSCanto II flow cytometer (BD Biosciences).
Statistical analysis
Medians and levels of significance were determined using Mann-Whitney test (GraphPad
Prism v6.05, La Jolla, CA, USA) as indicated. Two-sided probability (P) values< 0.05 were
considered significant. Experiments were reproduced at least twice.
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Results
Intestinal colonization efficacies of E. coli, A. butzleri andC. jejuni and
infection-induced clinical sequelae of gnotobiotic IL-10-/- mice
In the present study we aimed to compare the immunopathological potential of A. butzeri with
the gram-negative intestinal pathogen C. jejuni and a commensal E. coli strain isolated from
the intestinal microbiota of a conventional mouse. To address this, we applied the gnotobiotic
IL-10-/- mouse model generated by broad-spectrum antibiotic treatment. Following peroral
infection with comparable bacterial loads of approximately 109 CFU on two consecutive days
(namely days 0 and 1) by gavage, E. coli, A. butzleri strains CCUG 30485 and C1 as well as C.
jejuni were stably colonizing the intestinal tract of gnotobiotic IL-10-/- mice, as indicated by
high median bacterial loads of between 108 and 109 CFU per g feces (Fig 1). At day of necropsy
(i.e. day 6 p.i.), small and large intestinal A. butzleri loads were between one and three orders of
magnitude lower in colonic and ileal luminal contents, respectively, as compared to E. coli and
C. jejuni infected mice (p<0.05–0.001; Fig 2). Analysis of the clinical outcome of infection
revealed that C. jejuni infected mice were severely compromized at day 6 p.i., as indicated by
increased clinical scores (Fig 3A), and presented with wasting ulcerative enterocolitis including
bloody diarrhea (Fig 3B). Infection with the commensal E. coli or with either A. butzleri strain,
Fig 1. Kinetic survey of fecal bacterial shedding in perorally infected gnotobiotic IL-10-/- mice.Gnotobiotic IL-10-/- mice were
generated by antibiotic treatment and perorally colonized either with (A) a commensal E. coli strain, (B) A. butzleri strain C1, (C) A.
butzleri strain CCUG 30485 or (D) C. jejuni strain 81-176 at day 0 and day 1 by gavage. Bacterial loads were determined in fecal
samples (CFU / g, colony forming units per gram) over six days (d) post infection (p.i.) by culture. Medians (black bars) are
indicated.
doi:10.1371/journal.pone.0159685.g001
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however, induced, if any, only rather minor symptoms (Fig 3A), and neither gross nor occult
blood could be detected in fecal samples at day 6 p.i. at all (Fig 3B). Taken together, following
stable infection, C. jejuni, but neither A. butzleri strain nor commensal E. coli induced macro-
scopic disease.
Fig 2. Bacterial colonization alongside the intestinal tract of perorally infected gnotobiotic IL-10-/- mice.Gnotobiotic IL-10-/- mice
were generated by antibiotic treatment and perorally colonized either with a commensal E. coli strain, A. butzleri strain C1, A. butzleri
strain CCUG 30485 or C. jejuni strain 81-176 at day 0 and day 1 by gavage. Colonization densities were determined in luminal samples
derived from the (A) ileum and (B) colon (CFU / g, colony forming units per gram) at day 6 post infection by culture. Medians (black bars)
and levels of significance (* p<0.05; ** p<0.01; *** p<0.001) determined by Mann-Whitney U test are indicated.
doi:10.1371/journal.pone.0159685.g002
Fig 3. Macroscopic sequelae (disease activity) in perorally infected gnotobiotic IL-10-/- mice.Gnotobiotic IL-10-/- mice were
generated by antibiotic treatment and perorally colonized either with a commensal E. coli strain, A. butzleri strain C1, A. butzleri strain
CCUG 30485 or C. jejuni strain 81-176 at day 0 and day 1 by gavage. Naive mice served as uninfected controls. (A) Disease activity
(symptoms) and (B) occurrence of blood in fecal samples (bloody diarrhea) were quantitatively assessed at day 6 postinfection applying
respective standardized scores. Medians (black bars) and levels of significance (* p<0.05; *** p<0.001) determined by Mann-Whitney
U test are indicated.
doi:10.1371/journal.pone.0159685.g003
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Induction of apoptosis in the colon of infected gnotobiotic IL-10-/- mice
We next raised the question whether despite absence of macroscopic disease A. butzleri had the
potential to induce more distinct microscopic sequelae of infection than a gram-negative com-
mensal. Given that apoptosis is a commonly used diagnostic marker in the histopathological
evaluation and grading of intestinal disease [23] and a hallmark of C. jejuni induced enterocoli-
tis in gnotobiotic IL-10-/- mice [17], we quantitatively assessed numbers of caspase-3+ cells
within the colonic epithelium of infected mice. Whereas apoptotic cell numbers in the colonic
mucosa increased multi-fold until day 6 following C. jejuni infection (p<0.001; Fig 4), there
was a trend towards higher abundance of colonic apoptotic cells in A. butzleri strain CCUG
30485 as compared to E. coli infected and naive mice (n.s. after pooling of data sets; Fig 4).
Hence, our data indicate that the potential of A. butzleri to induce macroscopic or microscopic
intestinal disease does not exceed that of a commensal bacterial strain.
Large intestinal immune cell responses in infected gnotobiotic IL-10-/-
mice
Given that recruitment of pro-inflammatory immune cells to sites of inflammation is a key fea-
ture of infectious enteric diseases including campylobacteriosis [23], we next quantitatively
assessed effector as well as innate and adaptive immune cells within the large intestinal mucosa
and lamina propria by in situ immunohistochemical staining of colonic paraffin sections. At
day 6 p.i., naive and E. coli infected gnotobiotic IL-10-/- mice displayed comparable colonic
numbers of CD3+ T lymphocytes, FOXP3+ regulatory T cells (Tregs), B220+ B lymphoctyes
and F4/80+ macrophages and monocytes (Fig 5). Upon A. butzleri infection with either strain
or C. jejuni, however, colonic T cell numbers increased (p<0.001; Fig 5A), and reached highest
counts in C. jejuni infected mice. Whereas large intestinal numbers of Tregs and B lymphocytes
in E. coli and A. butzleri C1 strain infected mice did not differ from naive controls, respective
cell numbers increased following A. butzleri strain CCUG 30485 or C. jejuni with highest Treg
and B cell counts at day 6 following C. jejuni infection (p<0.001; Fig 5B, 5C and 5D). Interest-
ingly, numbers of macrophages and monocytes increased upon C. jejuni and A. butzleri infec-
tion (p<0.001; Fig 5D), but notably, less distinctly in C. jejuni infected mice (p<0.05–0.001;
Fig 5D). Hence, A. butzleri (and more distinctly strain CCUG 30485 than strain C1) as well as
C. jejuni, but not commensal E. coli infection, resulted in recruitment of pro-inflammatory
immune cells into the colonic mucosa and lamina propria at day 6 p.i.
Large intestinal pro-inflammatory cytokine secretion following A. butzleri,
E. coli or C. jejuni infection of gnotobiotic IL-10-/- mice
We next compared colonic secretion of pro-inflammatory cytokines upon infection with either
A. butzleri, E. coli or C. jejuni. Colonic IFN-γ, TNF, IL-6, and MCP-1 concentrations increased
until day 6 following C. jejuni infection (p<0.05—p<0.001; Fig 6), whereas respective cyto-
kines were also higher in the colon of A. butzleri strain CCUG 30485 (p<0.05–0.001; Fig 6)
and for MCP-1 also in C1 strain infected as compared to naive mice (p<0.05; Fig 6D).
Remarkably, colonic TNF, IL-6 and MCP-1 levels did not differ between strain CCUG 30485
and C. jejuni infected mice at day 6 p.i. (Fig 6B, 6C and 6D). Unexpectedly, increased large
intestinal IFN-γ and TNF concentrations could also be observed in commensal E. coli as com-
pared to uninfected mice (p<0.001 and p<0.01, respectively; Fig 6A and 6B), whereas only
colonic TNF was lower 6 days following E. coli versus CCUG 30485 strain infection (p<0.05;
Fig 6B). Taken together, in the large intestines distinct pro-inflammatory cytokines are
increased upon A. butzleri CCUG 30485, but not C1 strain infection, and, except for INF-γ, did
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not differ from C. jejuni infected mice, hence supporting a strain-dependent pro-inflammatory
potential of A. butzleri in the colon upon peroral infection.
Small intestinal pro-inflammatory cytokine secretion following A. butzleri,
E. coli or C. jejuni infection of gnotobiotic IL-10-/- mice
Even though gnotobiotic IL-10-/- mice are considered a suitable model for severe C. jejuni
induced colonic disease [17, 18], we addressed whether peroral infection with the respective
Fig 4. Apoptotic cells in colonic epithelium of perorally infected gnotobiotic IL-10-/- mice.Gnotobiotic IL-10-/- mice were
generated by antibiotic treatment and perorally colonized either with a commensal E. coli strain, A. butzleri strain C1, A. butzleri
strain CCUG 30485 or C. jejuni strain 81-176 at day 0 and day 1 by gavage. Naive mice served as uninfected controls. The average
numbers of apoptotic cells (positive for caspase-3, Casp3) from at least six high power fields (HPF, 400x magnification) per animal
were determined microscopically in immunohistochemically stained colonic paraffin sections at day 6 postinfection. Medians (black
bars) and levels of significance (* p<0.05; *** p<0.001) determined by Mann-Whitney U test are indicated.
doi:10.1371/journal.pone.0159685.g004
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bacterial strains might also affect pro-inflammatory cytokine secretion in the small intestinal
tract. In fact, 6 days following C. jejuni infection, increased ileal IFN-γ, TNF and IL-6, but not
MCP-1 concentrations could be measured (p<0.05–0.001; Fig 7). Remarkably, elevated IFN-γ,
IL-6 and MCP-1 levels could be determined at day 6 post CCUG 30485 strain infection
(p<0.05–0.001; Fig 7A, 7C and 7D), that did, however, not differ from ileal secretion in C.
jejuni infected mice. Moreover, both, IFN-γ and IL-6 increased upon A. butzleri C1 strain
Fig 5. Colonic immune cell responses in perorally infected gnotobiotic IL-10-/- mice.Gnotobiotic IL-10-/- mice were generated by
antibiotic treatment and perorally colonized either with a commensal E. coli strain, A. butzleri strain C1, A. butzleri strain CCUG 30485
or C. jejuni strain 81-176 at day 0 and day 1 by gavage. Naive mice served as uninfected controls. The average number of cells
positive for (A) CD3 (T lymphocytes), (B) FOXP3 (regulatory T cells, Tregs), (C) B220 (B lymphocytes) and (D) F4/80 (macrophages
and monocytes) from at least six high power fields (HPF, 400x magnification) per animal were determined microscopically in
immunohistochemically stained colonic paraffin sections at day 6 postinfection. Medians (black bars) and levels of significance
(* p<0.05; ** p<0.01; *** p<0.001) determined by Mann-Whitney U test are indicated.
doi:10.1371/journal.pone.0159685.g005
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infection (p<0.05 and p<0.001, respectively; Fig 7A and 7C), but less distinctly for the former
as compared to CCUG 30485 strain infection (p<0.05; Fig 7A). Taken together, A. butzleri
strain C1 and more distinctly strain CCUG 30485 as well as C. jejuni, but not E. coli infection is
accompanied with increased pro-inflammatory cytokines in the ileum pointing towards a pro-
nounced, but strain-dependent pro-inflammatory potential of Arcobacter also in the small
intestinal tract.
Fig 6. Colonic pro-inflammatory cytokine secretion in perorally infected gnotobiotic IL-10-/- mice.Gnotobiotic IL-10-/- mice were
generated by antibiotic treatment and perorally colonized either with a commensal E. coli strain, A. butzleri strain C1, A. butzleri strain
CCUG 30485 or C. jejuni strain 81-176 at day 0 and day 1 by gavage. Naive mice served as uninfected controls. Concentrations of (A)
IFN-γ, (B) TNF, (C) IL-6, and (D)MCP-1 were determined in supernatants of colonic ex vivo biopsies at day 6 postinfection by cytometric
bead assay. Medians (black bars) and levels of significance (* p<0.05; ** p<0.01; *** p<0.001) determined by Mann-Whitney U test are
indicated.
doi:10.1371/journal.pone.0159685.g006
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Bacterial translocation to extra-intestinal and systemic compartments
following A. butzleri, E. coli or C. jejuni infection of gnotobiotic IL-10-/-
mice
We next addressed whether respective bacterial infections were accompanied by translocation
of viable bacteria from the intestines to extra-intestinal compartments including the systemic
circulation. In more than 75% of diseased C. jejuni infected mice suffering from severe entero-
colitis and more than half of uncompromized E. coli infected animals, respective strains could
be isolated from MLN at day 6 p.i, whereas A. butzleri was virtually undetectable (Fig 8A).
Fig 7. Ileal pro-inflammatory cytokine secretion in perorally infected gnotobiotic IL-10-/- mice.Gnotobiotic IL-10-/- mice were
generated by antibiotic treatment and perorally colonized either with a commensal E. coli strain, A. butzleri strain C1, A. butzleri strain
CCUG 30485 or C. jejuni strain 81-176 at day 0 and day 1 by gavage. Naive mice served as uninfected controls. Concentrations of (A)
IFN-γ, (B) TNF, (C) IL-6, and (D)MCP-1 were determined in supernatants of ileal ex vivo biopsies at day 6 postinfection by cytometric
bead assay. Medians (black bars) and levels of significance (* p<0.05; ** p<0.01; *** p<0.001) determined by Mann-Whitney U test are
indicated.
doi:10.1371/journal.pone.0159685.g007
Arcobacter butzleri: Pathogen or Commensal?
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Furthermore, 5.9% of E. coli infected, 33.3% of A. butzleri strain C1 infected, 20.0% of A. but-
zleri strain CCUG 30485, and 9.5% of C. jejuni infected mice harbored viable bacteria in their
livers (Fig 8C). In systemic compartments such as the spleen and cardiac blood, however, via-
ble bacteria were virtually undetectable (Fig 8B and 8D). Hence, in contrast to commensal E.
coli and pathogenic C. jejuni, A. butzleri could not be cultured fromMLN, whereas neither
strain translocated further to extra-intestinal including systemic compartments.
Systemic pro-inflammatory immune responses following A. butzleri, E.
coli or C. jejuni infection of gnotobiotic IL-10-/- mice
We next addressed whether despite lack of translocating bacteria to extra-intestinal tissue sites,
systemic immune responses were induced upon peroral infection. In fact, at day 6 following C.
Fig 8. Bacterial translocation in perorally infected gnotobiotic IL-10-/- mice.Gnotobiotic IL-10-/- mice were generated by antibiotic
treatment and perorally colonized either with a commensal E. coli strain, A. butzleri strain C1, A. butzleri strain CCUG 30485 or C.
jejuni strain 81-176 at day 0 and day 1 by gavage. Naive mice served as uninfected controls. Bacterial translocation was quantitatively
assessed in homogenates of (A)mesenteric lymph nodes (MLN) (B) spleen, (C) liver, and (D) cardiac blood at day 6 postinfection by
culture (direct plating). Medians (black bars), numbers of mice harboring the respective bacterial species out of the total number of
analyzed animals (in parenthesis), and levels of significance (* p<0.05; ** p<0.01; *** p<0.001) determined by Mann-Whitney U test
are indicated.
doi:10.1371/journal.pone.0159685.g008
Arcobacter butzleri: Pathogen or Commensal?
PLOS ONE | DOI:10.1371/journal.pone.0159685 July 20, 2016 12 / 18
jejuni infection, increased IFN-γ, TNF, IL-6 and MCP-1 serum levels could be measured
(p<0.001; Fig 9), whereas E. coli infection resulted in elevated IFN-γ and TNF serum concen-
trations (Fig 9A and 9B). Moreover, MCP-1 serum levels increased until day 6 following A.
butzleri infection with either strain (p<0.001; Fig 9D) and were comparable to those obtained
from C. jejuni infected mice, whereas serum IFN-γ was higher in CCUG 30485, but not C1
strain infected mice as compared to naive animals (p<0.01; Fig 9A). Hence, despite absence of
viable bacteria from the circulation increased levels of pro-inflammatory cytokines in sera
could be observed at day 6 p.i. with highest concentrations in C. jejuni infected mice, whereas
Fig 9. Systemic pro-inflammatory cytokine secretion in perorally infected gnotobiotic IL-10-/- mice.Gnotobiotic IL-10-/- mice were
generated by antibiotic treatment and perorally colonized either with a commensal E. coli strain, A. butzleri strain C1, A. butzleri strain
CCUG 30485 or C. jejuni strain 81-176 at day 0 and day 1 by gavage. Naive mice served as uninfected controls. Concentrations of (A)
IFN-γ, (B) TNF, (C) IL-6, and (D)MCP-1 were determined in serum samples taken at day 6 postinfection. Medians (black bars) and
levels of significance (* p<0.05; ** p<0.01; *** p<0.001) determined by Mann-Whitney U test are indicated.
doi:10.1371/journal.pone.0159685.g009
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increased MCP-1 serum levels were comparable in C. jejuni, A. butzleri strains CCUG 30485
and C1 infected mice.
Taken together, A. butzleri is able to induce pro-inflammatory responses in perorally
infected gnotobiotic IL-10-/- mice in a strain-dependent manner. Overall, however, the pro-
inflammatory potential of A. butzleri is far less pronounced than for C. jejuni, but more distinct
as compared to a commensal E. coli strain. Particularly in the small intestines, increased cyto-
kine levels could be observed that did not differ between A. butzleri and C. jejuni infected mice.
Discussion
In the present study we aimed to shed more light onto the controversy whether Arcobacter
should be regarded as an ordinary commensal species (such as E. coli) or rather a serious intes-
tinal pathogen (such as Campylobacter) in vivo. To address this, we performed a comparative
survey on intestinal, extra-intestinal and systemic sequelae upon infection of gnotobiotic IL-
10-/- mice with a commensal E. coli strain, the intestinal pathogen C. jejuni and two different A.
butzleri strains. The C. jejuni infected gnotobiotic IL-10-/- mice developed wasting, non-self-
limiting acute enterocolitis within one week [17, 18, 20, 24], whereas mice infected with a com-
mensal E. coli strain did not exhibit any macroscopic or microscopic sequelae [17, 18]. As upon
E. coli challenge, A. butzleri infected mice were clinically virtually uncompromized. This is
rather surprising given that in vitro studies revealed adhesive, invasive and also cytotoxic prop-
erties of A. butzleri [22, 25–31]. Furthermore, A. butzleri infection of a human colon cell line
resulted in a compromized epithelial barrier pointing towards a potential mechanism by which
diarrhea is induced in Arcobacter infected humans [32].
Notably, before our previous reports on A. butzleri infected gnotobiotic IL-10-/- mice [13–
16], only one single in vivo study in mice had been published showing that the adherent prop-
erties of initially low-adherent A. butzleri strains were enhanced upon serial intraperitoneal
passages [33]. Our murine A. butzleri infection studies, however, clearly revealed that despite
absence of overt gross disease, distinct infection-induced intestinal, extra-intestinal and even
systemic sequelae could be observed in an A. butzleri strain dependent manner [13–16]. These
results indicate that gnotobiotic IL-10-/- mice might serve as infection model to investigate
Arcobacter-host interactions to some extent. One could argue, however, that differences in phe-
notypes observed in C. jejuni and A. butzleri infected mice might have been due to differences
in bacterial colonization status of mice, given that A. butzleri loads in the large and small intes-
tines were between 2 and 3 orders of magnitude lower as compared to C. jejuni (but also E.
coli). Considering the high bacterial burdens of 108–109 CFU viable bacteria per gram luminal
colon sample and 103–106 CFU per gram luminal ileum sample however, it is questionable
whether the observed differences might have such an biological impact explaining the discrep-
ancies in disease outcome.
Despite the lack of clinical and histopathological sequelae, however, A. butzleri induced a
marked influx of effector cells as well as of innate and adaptive immune cells into the colonic
mucosa and lamina propria of infected gnotobiotic IL-10-/- mice, again in a strain-dependent
fashion. Increases in Tregs, T and B lymphocytes were more pronounced following C. jejuni as
compared to A. butzleri infection, but interestingly, the other way round was true for macro-
phages and monocytes. These results are well in line with leukocytic infiltrates that were
observed in the intestinal lamina propria of A. butzleri infected albino rats [34]. It is tempting
to speculate that these innate immune cells eradicate the bacteria and limit the systemic out-
come of arcobacteriosis. This assumption is further supported by the fact that viable A. butzleri
were virtually undetectable in MLN and extra-intestinal including systemic compartments.
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Furthermore, increased colonic abundances of immune cells were accompanied by elevated
concentrations of pro-inflammatory cytokines, not only in the large, but also small intestines
following C. jejuni as well as A. butzleri infection. These findings are in line with results from
an in vitro study demonstrating that A. butzleri infection of THP-derived macrophages
resulted in an increased expression of pro-inflammatory cytokines including TNF and IL-6
[35]. Remarkably, despite the devastating and non-self-limiting phenotype following C. jejuni,
but not A. butzleri infection, levels of distinct pro-inflammatory cytokines were comparable in
intestinal and even in systemic compartments of C. jejuni or A. butzleri infected mice as indi-
cated by comparable IL-6 and MCP-1 concentrations in ileum and colon, and the latter addi-
tionally in serum samples. Hence, A. butzleri induce not only intestinal, but also systemic
immune responses, and this exceeds the pathogenic properties of a “merely” bacterial
commensal.
Overall, the observed A. butzleri induced immune responses were more pronounced upon
strain CCUG 30485 (initially isolated from a diarrheal patient) as compared to strain C1
(derived from fresh chicken meat) as indicated by higher abundances of apoptotic and immune
cell populations in the colonic mucosa and higher pro-inflammatory cytokine levels such as
TNF (in colon) and IFN-γ (in colon, ileum and serum) in strain CCUG 30485 versus strain C1
infected mice. It is even highly likely that different A. butzleri strains induce distinct host-
dependent immune responses given that in humans some strains induce overt disease, whereas
in chickens other strains behave like commensals [36]. This is supported by in vitro results
revealing that different A. butzleri strains exerted different adhesive and invasive properties
[22, 25, 31, 37], even though no direct correlation between respective phenotypes and corre-
sponding gene patterns or functional adhesion and invasion associated gene domains could be
found [22, 25]. Nevertheless, both A. butzleri strains applied in our study exerted similar viru-
lence gene patterns and comparable capabilities of adhesion and invasion in vitro [22, 31].
Previous in vivo studies revealed that the virulence potential of Arcobacter was not only
strain-dependent, but also correlated with host factors such as animal species and breed. For
instance, certain turkey strains such as Beltsville white turkeys could be colonized by A. butzleri
with variable loads and displayed mortality rates in a strain dependent manner, whereas A. but-
zleri was unable to readily colonize turkey poults and conventional chicken [38].
Recent investigations revealed that A. butzleri induced small and large intestinal as well as
extra-intestinal and systemic immune responses were TLR-4 dependent [15, 16]. The fact that
Arcobacter strains express variable LPS or LOS structures might further determine whether a
specific strain rather acts as a pathogen or a commensal in a susceptible or resistant host. To
date, however, neither A. butzleri LOS nor LPS have been isolated. In halophilic A. halophilus,
however, the carbohydrate backbone of LOS has been characterized in detail [39].
In conclusion, A. butzleri induce less distinct pro-inflammatory sequelae as compared to C.
jejuni, but more pronounced local (i.e intestinal) and systemic immune responses than com-
mensal E. coli in a strain-dependent manner. Overall, these results are in line with the relatively
low pathogenic potential of A. butzleri observed in humans, but do, in fact, point towards a
immunopathogenic potential of A. butzleri in vertebrate hosts in general.
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